ZRO — BIOSENTA Balance Sheet
0.000.00%
- CA$2.81m
- CA$3.47m
- CA$0.00m
Annual balance sheet for BIOSENTA, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.112 | 0.027 | 0.006 | 0.009 | 0.026 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.003 | 0.139 | 0.02 | 0.046 | 0.01 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.264 | 0.256 | 0.092 | 0.101 | 0.074 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0 | — | 0.016 | 0.013 | 0.036 |
| Net Intangible Assets | |||||
| Total Assets | 0.264 | 0.256 | 0.108 | 0.114 | 0.11 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.8 | 3.12 | 2.67 | 2.53 | 10.1 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 2.86 | 3.18 | 7.96 | 7.99 | 10.2 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -2.59 | -2.92 | -7.86 | -7.88 | -10.1 |
| Total Liabilities & Shareholders' Equity | 0.264 | 0.256 | 0.108 | 0.114 | 0.11 |
| Total Common Shares Outstanding |